ライフサイエンスコーパス: catheterization

1 ght be damaged after cannulation for cardiac catheterization.

2 inpatient status at the time of right heart catheterization.

3 in coronary artery bypass grafting after its catheterization.

4 cia stuartii, commonly occurs with long-term catheterization.

5 echocardiography when compared with cardiac catheterization.

6 nexplained dyspnea who underwent right heart catheterization.

7 ause mortality over 90 days and 1 year after catheterization.

8 eumothorax than jugular-vein or femoral-vein catheterization.

9 s of interest included safety and failure of catheterization.

10 k in a cohort of patients undergoing cardiac catheterization.

11 comes in children with PH undergoing cardiac catheterization.

12 rdiac treatments, and outcomes after cardiac catheterization.

13 riencing a major adverse event after cardiac catheterization.

14 specificity to detect selective adrenal vein catheterization.

15 rization to reduce adverse events and failed catheterization.

16 e patients (1.49%) undergoing femoral artery catheterization.

17 que in adult patients undergoing right heart catheterization.

18 ical Coherence Tomography during Right Heart catheterization.

19 life-threatening complication after cardiac catheterization.

20 Hg on echocardiogram underwent a right heart catheterization.

21 dder scanner and those measured with bladder catheterization.

22 through barriers in timely access to cardiac catheterization.

23 dial artery becomes obstructed after cardiac catheterization.

24 o develop more tamponades during transseptal catheterization.

25 systolic elastance (Ees), requires invasive catheterization.

26 nt dose and operator exposure during cardiac catheterization.

27 opeptide of type I collagen) and right heart catheterization.

28 anted in all participants during right heart catheterization.

29 in right atrial pressure during right heart catheterization.

30 ngle and multi-use) package for intermittent catheterization.

31 ata regarding race or the diagnostic cardiac catheterization.

32 years old and undergoing diagnostic cardiac catheterization.

33 f upper-extremity function after transradial catheterization.

34 gnetic resonance imaging and pressure volume catheterization.

35 s of imaging-guided transhepatic intraportal catheterization.

36 234 patients undergoing transradial cardiac catheterization.

37 cline in excess mortality associated with PA catheterization.

38 ut definitive diagnosis requires right-heart catheterization.

39 , reporting 655 patients, 757 eyes, and 2350 catheterizations.

40 with serial echocardiograms and right heart catheterizations.

41 mind before common interventions such as UV catheterizations.

42 reported procedure was performed in >95% of catheterizations.

43 tract infections and need for transient self-catheterizations.

44 isk-adjusted odds ratio for mortality for PA catheterization, 1.66 (95% confidence interval, 1.60-1.7

45 per 1000 CHD patients in diagnostic cardiac catheterizations (11.7 to 13.7 per 1000), structural hea

46 ively all US veterans undergoing right heart catheterization (2007-2012) in the Veterans Affairs heal

47 In patients with right heart catheterization (30 HF-PH, 14 PVOD), similar association

48 01), and were less likely to undergo cardiac catheterization (33.8% vs 77.8%; AOR, 0.19; 95% CI, 0.16

49 Participants underwent a second catheterization 4 weeks later for measurement of dP/dt.

50 associated with more revascularizations and catheterizations (4.25 per 100 patients) with CTA use.

51 aggressive interventions, including cardiac catheterization (60.7% versus 54.0%; P<0.001), percutane

52 After catheterization, a transvenous pacing catheter was place

53 fety and feasibility of transradial coronary catheterization across the whole spectrum of Allen test

54 circulatory support within 1 day of cardiac catheterization after adjustment for patient- and proced

55 -one adult Fontan patients underwent cardiac catheterization; age 26+/-3 years, men 146 (56%), atriop

56 ry wedge pressure </=15 mm Hg at right heart catheterization (allele frequency, 0.66; odds ratio, 13.

57 Together, these data suggest that catheterization alters the urinary tract environment to

58 long-axis view for subclavian central venous catheterization and avoiding posterior wall penetrations

59 measurements were assessed using right heart catheterization and cardiac MRI.

60 0.45-16.5 years) underwent combined cardiac catheterization and cardiovascular magnetic resonance.

61 COPD patients who underwent both right heart catheterization and computed tomography in a period of s

62 nary syndrome patients enrolled in the Acute Catheterization and Early Intervention Triage Strategy (

63 Right heart catheterization and echocardiography were performed whil

64 catheter system is feasible for renal artery catheterization and embolization under real-time MR imag

65 undergoing simultaneous right and left heart catheterization and estimated associations of eGFR with

66 s who underwent first diagnostic right heart catheterization and from a prospective cohort of 800 con

67 riteria included the need for urgent cardiac catheterization and history of ACS or coronary revascula

68 s in 54 pediatric PH patients during cardiac catheterization and in 54 matched controls.

69 and Adult Congenital Treatment) for cardiac catheterization and intervention for pediatric and adult

70 therapy; patients also underwent right-heart catheterization and LSM at these time points.

71 hips between nSES and the receipt of cardiac catheterization and mortality after acute coronary syndr

72 tion between nSES and the receipt of cardiac catheterization and mortality after an acute coronary sy

73 rwent detailed reassessment with right heart catheterization and noninvasive testing at 3 to 6 months

74 tal quality programs: 1) CathPCI (Diagnostic Catheterization and Percutaneous Coronary Intervention)

75 risk stratification of patients for cardiac catheterization and possible percutaneous coronary inter

76 siological assessment with right-sided heart catheterization and radionuclide ventriculography at res

77 emodynamic variables obtained by right heart catheterization and transpulmonary thermodilution measur

78 (Acute Catheterization and Urgent Intervention Triage Strategy

79 ocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy

80 and troponin elevation enrolled in the Acute Catheterization and Urgent Intervention Triage Strategy

81 All patients from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy)

82 s in Myocardial Infarction [TIMI], and Acute Catheterization and Urgent Intervention Triage) and requ

83 dient agreement between echocardiography and catheterization and was associated with a measurable dec

84 ic resonance (MR) imaging, right-sided heart catheterization, and 6-minute walk testing with a median

85 cardiac magnetic resonance imaging, cardiac catheterization, and echocardiography) and indexed to bo

86 d in 54 pediatric PH patients during cardiac catheterization, and in 54 matched controls.

87 rimary outcome measure was agreement between catheterization- and echocardiography-derived mean gradi

88 using systematic confirmation on right heart catheterization are lacking.

89 Women veterans undergoing catheterization are younger, have more obesity, depressi

90 , including echocardiography and right heart catheterization, are key elements in the assessment.

91 of age with PH undergoing 1 or more cardiac catheterization at centers participating in the Pediatri

92 ted by pulmonary hypertension at right-heart catheterization at days 21 to 35 and major remodeling of

93 4 HFpEF; n=12 control) underwent right heart catheterization at rest, during supine exercise, and wit

94 on sequences were used for MR imaging-guided catheterization, balloon dilation, and stent implantatio

95 In this large catheterization-based study, the coexistence of PLF-AS b

96 opted as the primary access site for cardiac catheterization because of patient preference, lower ble

97 us for all patients referred for right heart catheterization between 1998 and 2014.

98 ergoing diagnostic or interventional cardiac catheterization between January 2011 and March 2013.

99 rans (3181 women) undergoing initial cardiac catheterization between October 1, 2007, and September 3

100 ischemic heart disease confirmed on cardiac catheterization between October 1, 2008, and September 3

101 Contrast media administered during cardiac catheterization can affect hemodynamic variables.

102 f an entire guide wire during central venous catheterization can lead to serious patient harm and req

103 or adverse outcomes after congenital cardiac catheterization can support reporting of risk-adjusted o

104 Younger age at catheterization, cardiac operation in the same admission

105 =6]) were evaluated monthly with right heart catheterization, CMR, and computed tomography during 4 m

106 trasound-assisted right-sided central venous catheterization compared with 92 serial historic control

107 ndrome who had complete baseline right heart catheterization data from the Fluid and Catheter Treatme

108 ure, we retrospectively assessed right heart catheterization data in 162 consecutive patients with ou

109 Among cases with available catheterization data pre- and post-CQI, the coverage pro

110 Echocardiographic and catheterization data were obtained during routine care.

111 is echocardiography studies with concomitant catheterization data, and deidentified individual and gr

112 A catheterization database that records the occurrence of

113 New York State's Cardiac Diagnostic Catheterization Database was used to identify patients u

114 res on the total air kerma during diagnostic catheterization (DC) and percutaneous interventions (PCI

115 Appropriate use criteria for diagnostic catheterization (DC) were recently published.

116 During 2001 to 2006, PA catheterization declined across hospitals; however, in 2

117 ived CI (r=0.7; P<0.001), as well as cardiac catheterization-derived CI (r=0.6; P<0.001).

118 acute changes in preload and correlated with catheterization-derived indices of RV contractility in h

119 nal echo, 2-dimensional speckle tracking and catheterization-derived parameters during different stat

120 th DTs and DTr correlating with simultaneous catheterization-derived stiffness (dP/dV) and relaxation

121 h a prespecified acceptable echocardiography-catheterization difference of <10 mm Hg in mean gradient

122 years of age presenting for routine cardiac catheterization during 2015 to 2016.

123 ve hemodynamic ramp testing with right heart catheterization, during which LVAD speeds were adjusted.

124 3.1+/-0.7) and 40 HF-free controls underwent catheterization, echocardiography, and follow-up.

125 ongestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) data set (n=390).

126 ongestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) trial were included (n =

127 ongestive Heart Failure and Pulmonary Artery Catheterization Effectiveness], CHARM [Candesartan in He

128 e of subclavian vein catheterization reduces catheterization failures and adverse events compared to

129 four patients undergoing nonemergent cardiac catheterization followed by treatment (ie, 128 coronary

130 rence of a major adverse event after cardiac catheterization for congenital heart disease.

131 en undergoing a clinically indicated cardiac catheterization for evaluation of PAH and pulmonary vaso

132 the study period, 136 patients underwent 139 catheterizations for attempted Melody TPVR with a median

133 atients underwent biventricular EMB, cardiac catheterization (for exclusion of coronary artery diseas

134 plication cohort of 245 individuals from the Catheterization Genetics biorepository.

135 ough ultrasound guidance for subclavian vein catheterization has been well described, evidence for it

136 The field of cardiac catheterization has evolved, performing more interventio

137 es of lost guide wires during central venous catheterization has increased rapidly.

138 hen culturing urine obtained by "in-and-out" catheterization in a selected female population.

139 ompared to landmark technique for subclavian catheterization in adult populations were considered.

140 ation procedure was performed before cardiac catheterization in all patients, except for those (n=78,

141 )]apelin-13 were assessed by MRI and cardiac catheterization in anesthetized rats.

142 ent advances in echocardiography and cardiac catheterization in assessment of aortic stenosis, anesth

143 The risk of cardiac catheterization in children and young adults with PH is

144 low-dose UFH (50 U/kg bolus) during cardiac catheterization in children.

145 substantial hospital-level variability in PA catheterization in HF along with increasing volume at fe

146 registry of all patients undergoing cardiac catheterization in Ontario, to evaluate patients treated

147 randomly assigned nontunneled central venous catheterization in patients in the adult intensive care

148 ne use of fluid challenge during right heart catheterization in patients with risk factors for PVH.

149 ears; 3.3% female) who underwent right heart catheterization in this cohort study, Td and eFick CI es

150 than 15000 adults who underwent right heart catheterization, including 12232 in the Veterans Affairs

151 ed a mouse model of CAUTI to investigate how catheterization increases an individual's susceptibility

152 g-axis approach to subclavian central venous catheterization is also associated with fewer posterior

153 ltrasound-guided right internal jugular vein catheterization is exceedingly low.

154 ltrasound-guided right internal jugular vein catheterization is exceedingly low.

155 for adverse events after congenital cardiac catheterization is needed to equitably compare patient o

156 Diagnosis is made when heart catheterization is performed in the work up for acute co

157 Cardiac catheterization is the standard of care procedure for di

158 , Reporting, and Tracking System for Cardiac Catheterization Laboratories (CART-CL) program.

159 data on all CAs and PCIs performed in the 36 catheterization laboratories in the Greater Paris Area,

160 ty improvement activity performed in cardiac catheterization laboratories, but best practices for cas

161 CART) program representing all 76 VA cardiac catheterization laboratories, we evaluated all patients

162 sfer from the STEMI referral hospital to the catheterization laboratory (cath lab) at the STEMI recei

163 vel protocol of early transport to a cardiac catheterization laboratory (CCL) for extracorporeal life

164 he median OxPL/apoB presented to the cardiac catheterization laboratory a mean of 3.9 years earlier (

165 y care processes increased after prehospital catheterization laboratory activation (62%-91%; P<0.001)

166 ), a first medical contact to device time to catheterization laboratory activation of </=20 minutes (

167 l infarction networks focused on prehospital catheterization laboratory activation, single call trans

168 ference between the patient's arrival at the catheterization laboratory and the patient's final angio

169 infarction, including time of arrival in the catheterization laboratory and time of first balloon inf

170 chemia will be the gatekeeper to the cardiac catheterization laboratory and will transform the world

171 We included all patients presenting to the catheterization laboratory at our institution after PMI

172 unctional LVOT conduit were evaluated in the catheterization laboratory between December 2008 and Aug

173 Particular adaptations to the cardiac catheterization laboratory environment are required to a

174 ecutive patients referred to the Mayo Clinic catheterization laboratory for hemodynamic assessment be

175 tcomes in patients presenting to the cardiac catheterization laboratory for myocardial infarction sus

176 s classified according to PCI center status (catheterization laboratory immediately accessible 24/7).

177 l process for developing an HOR in a cardiac catheterization laboratory in a VA designated for comple

178 X-ray use in the catheterization laboratory is guided by the principle of

179 site visit consisting of a National Chief of Catheterization Laboratory Managers, a cardiac surgeon,

180 l procedures were performed within a cardiac catheterization laboratory or hybrid operating room unde

181 procedural predictors were total time in the catheterization laboratory or operating room, delivery c

182 The catheterization laboratory protocol provides a model to

183 and early and consistent availability of the catheterization laboratory team.

184 the median time from arrival in the cardiac catheterization laboratory to first balloon was 27 minut

185 in the ambulance) versus in-hospital (in the catheterization laboratory) treatment with ticagrelor.

186 hospital ECGs, prehospital activation of the catheterization laboratory, bypassing geographically clo

187 In the catheterization laboratory, intravascular imaging provid

188 number of clinicians are using a strategy of catheterization laboratory-only eptifibatide (an off-lab

189 A catheterization laboratory-only eptifibatide regimen is

190 We used optimal matching to link the use of catheterization laboratory-only eptifibatide with clinic

191 alysis, compared with bolus plus infusion, a catheterization laboratory-only regimen was associated w

192 Of these, a catheterization laboratory-only regimen was used in 4511

193 olus plus infusion with those treated with a catheterization laboratory-only regimen.

194 in participants ascertained via the cardiac catheterization laboratory.

195 rdiopulmonary bypass or interventions in the catheterization laboratory.

196 ement of CI-AKI as it applies to the cardiac catheterization laboratory.

197 ot be recommended for decision making in the catheterization laboratory.

198 patients prior to activation of the cardiac catheterization laboratory.

199 dy supports the routine use of RADPAD in the catheterization laboratory.

200 s as to why we still need BMS in our cardiac catheterization laboratory.

201 Using right heart catheterization measurements, mild PH was defined as mea

202 es at echocardiography and right-sided heart catheterization, medications, chronic lung disease, blee

203 After each catheterization (n = 198), the main complications includ

204 echocardiographically (n=23) and by cardiac catheterization (n=5) after primary repair (n=4) or afte

205 The primary outcome was cardiac catheterization not leading to revascularization within

206 on the performance of left and right radial catheterization obtained during the same or during repea

207 For catheterization of branch vessels arising at large angle

208 AND Acute infarction was induced by cardiac catheterization of domestic swine.

209 After catheterization of the inferior vena cava, right atrium,

210 Each rat underwent catheterization of the right femoral artery and left fem

211 , intravascular procedures, including venous catheterization or injection.

212 -comer trial, patients undergoing diagnostic catheterization or percutaneous coronary interventions w

213 n of HF patients undergoing pulmonary artery catheterization (PAC).

214 ion (10%), and rarely in unrelated real-life catheterization patients (6%).

215 reference central BP waveforms from cardiac catheterization patients.

216 ELISAs using 72 plasma samples from cardiac catheterization patients.

217 imary outcome), invasive management (cardiac catheterization, PCI, or CABG), revascularization (PCI o

218 Reduced rates of cardiac catheterization, percutaneous coronary intervention (PCI

219 rdiac operation in the same admission as the catheterization, pre-procedural systemic vasodilator inf

220 Here, we introduce a catheterization procedure that keeps a rat physiological

221 scheduled for electrophysiology and cardiac catheterization procedures.

222 After catheterization, radial artery puncture site is associat

223 e who suffered mucosal injuries via urethral catheterization, rarely showed evidence of neutrophil in

224 Ultrasound-guided subclavian catheterization reduced the frequency of adverse events

225 ether ultrasound guidance of subclavian vein catheterization reduces catheterization failures and adv

226 t of other current and historical congenital catheterization registries.

227 from the 4 member centers of the Congenital Catheterization Research Collaborative.

228 levated troponins, and subsequent left heart catheterization revealed findings consistent with congen

229 nce imaging, and pressure-volume conductance catheterization revealed impaired cardiac function in 2-

230 with normal mPAP) who underwent right heart catheterization (RHC) and three-directional phase-contra

231 y hypertension (PH) diagnosed by right heart catheterization (RHC) are independent risk factors for m

232 alue of at least 25 mm Hg during right heart catheterization (RHC).

233 d 2016 who had a follow-up right-sided heart catheterization (RHC).

234 emonstrated a significant decrease in failed catheterization (risk ratio, 0.24; 95% CI, 0.06-0.92).

235 CTA was associated with fewer catheterizations showing no obstructive CAD than was fun

236 in vivo echocardiography and pressure-volume catheterization studies revealed impaired systolic funct

237 Simultaneous echocardiographic-catheterization studies were prospectively conducted at

238 somewhat higher than, measures derived from catheterization studies.

239 ighly with urine volumes measured by bladder catheterization (summary correlation coefficient, 0.93;

240 The evolution toward more selective catheterization techniques, resulting in more variable t

241 condary end points included invasive cardiac catheterization that did not show obstructive CAD and ra

242 Following catheterization, the patient's troponins began to trend

243 Mean catheterization time with MR guidance was 93 seconds +/-

244 ndling was rated on a three-point scale, and catheterization times for different vessel regions were

245 Afterward, handling ratings and catheterization times were obtained for standard nitinol

246 dvanced heart failure undergoing right heart catheterization to assess cardiac transplantation candid

247 hocardiography further underwent right heart catheterization to confirm the diagnosis of PAH (mean pu

248 use of dynamic 2D ultrasound for subclavian catheterization to reduce adverse events and failed cath

249 reports of lost wires during central venous catheterization to understand its possible etiology, pre

250 ural changes of the radial artery wall after catheterization to understand whether these might predic

251 isted catheterization was faster than manual catheterization under MR imaging guidance and was compar

252 The Radiation Reduction During Cardiac Catheterization Using Real-Time Monitoring study sought

253 eline characteristics, including right heart catheterization variables, were not consistently associa

254 l therapy with a sham procedure (right heart catheterization) versus medical therapy and PFO closure

255 r 2014, 42 patients underwent 47 attempts at catheterization via PCA.

256 nd coronary artery disease underwent cardiac catheterization via radial access and performed incremen

257 not routinely required for pediatric cardiac catheterization via the carotid artery.

258 netic resonance imaging was 1.82, by cardiac catheterization was 1.65, and by echo was 1.7 L.min(-1).

259 n 2001, the number of hospitals with >/=1 PA catheterization was 1753, decreasing to 1183 in 2011.

260 The confirmed PAH prevalence on right heart catheterization was 2.1% (95% confidence interval [CI],

261 Freedom from interventional catheterization was 53% at 15 years and 50% at 20 years.

262 The need for self-catheterization was 8% and 2% at 1 and 6 months in the o

263 long-axis view for subclavian central venous catheterization was also more efficient with decreased t

264 ar risk factors, the main reason for cardiac catheterization was an acute coronary syndrome (n=54).

265 Failure of catheterization was analyzed with inverse variance rando

266 In this trial, subclavian-vein catheterization was associated with a lower risk of bloo

267 p < 0.001); failure of internal jugular vein catheterization was associated with left-side insertion

268 Cardiac catheterization was common (71% and 51%), but percutaneo

269 a major adverse event or death after cardiac catheterization was derived in 70% of the cohort and val

270 ising at large angles, magnetically assisted catheterization was faster than manual catheterization u

271 Among experienced operators, catheterization was faster with x-ray guidance (20 secon

272 No difference in failure of catheterization was noted between the ultrasound group a

273 Pulmonary artery catheterization was performed before and after 1 year of

274 The benefits also persisted when cardiac catheterization was performed in control patients as wel

275 A single cardiac catheterization was performed on each patient with CO es

276 Right heart catheterization was performed using a pressure and Doppl

277 This analysis revealed that catheterization was required for MRSA to achieve high-le

278 Intranodal lymphangiogram and thoracic duct catheterization was successful in all patients.

279 Right ventricular catheterization was then performed, followed by quantita

280 al assays (including ileectomy and bile duct catheterization), we identify KLF15 as the first endogen

281 tic stenosis and a preprocedural right heart catheterization were assessed.

282 for the detection of selective adrenal vein catheterization were calculated for basal Ca/Cp ratio, A

283 ve patients within IMPACT undergoing cardiac catheterization were identified.

284 imultaneous echocardiography and right heart catheterization were prospectively performed in 50 conse

285 t RBBB pattern in lead V1 during right heart catheterization were studied.

286 A total of 19,608 cardiac catheterizations were performed between January 2011 and

287 f 202 adult patients with 219 central venous catheterizations were retrospectively analyzed.

288 cular EF (echocardiography) and then cardiac catheterization, where left ventricular pressure develop

289 ith LGSAS and preserved EF underwent cardiac catheterization with comparison of hemodynamic measureme

290 h bioprosthetic TV dysfunction who underwent catheterization with planned TVIV.

291 simultaneous echocardiography and left heart catheterization with pressure-conductance instrumentatio

292 th HFpEF (N = 28) underwent invasive cardiac catheterization with simultaneous expired gas analysis a

293 subjects with HFpEF (n=26) underwent cardiac catheterization with simultaneous expired gas analysis a

294 Of the 45 catheterizations with successful PCA and sheath placemen

295 A and 32 (16%) who had MPI underwent cardiac catheterization within 1 year.

296 azard ratio 1.96, P < 0.0001); (iii) urinary catheterization within 3 years of symptom onset (hazard

297 ed with a 6% lower odds of receiving cardiac catheterization within 30 days (P=0.01) and a 14% higher

298 associated with a 2% lower odds of receiving catheterization within 30 days (P=0.10) and a 5% higher

299 ugh more patients in the CTA group underwent catheterization within 90 days after randomization (12.2

300 ed that a fluid challenge during right heart catheterization would identify occult pulmonary venous h